A carregar...

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

BACKGROUND: One of the major challenges in diagnosing dementia with Lewy bodies (DLB) is the common co-morbid presence of amyloid pathology. To understand the putative role of altered amyloid-β (Aβ) metabolism in dementia with DLB, we analyzed levels of different cerebrospinal fluid (CSF) Aβ peptide...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: van Steenoven, Inger, van der Flier, Wiesje M., Scheltens, Philip, Teunissen, Charlotte E., Lemstra, Afina W.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6788069/
https://ncbi.nlm.nih.gov/pubmed/31601267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-019-0537-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!